A Possible Role of GLP-1 in the Pathophysiology of Early Dumping Syndrome

被引:0
|
作者
Hiroshi Yamamoto
Tsuyoshi Mori
Hiroshi Tsuchihashi
Hiroya Akabori
Hiroyuki Naito
Tohru Tani
机构
[1] Shiga University of Medical Science,The Department of Surgery
[2] Shiga University of Medical Science,Department of Surgery
来源
关键词
dumping syndrome; GLP-1; norepinephrine; sympathetic; insulin;
D O I
暂无
中图分类号
学科分类号
摘要
Exaggerated plasma concentrations of GLP-1 precede reactive hypoglycemia after oral glucose in gastrectomy patients, resulting in late dumping syndrome. Recently, we showed that GLP-1 elicits the activation of sympathetic outflow. Because sympathetic activation is thought to be a cause of early dumping, we hypothesized that exaggerated GLP-1 may contribute to the pathophysiology of early dumping syndrome. In 11 patients after gastrectomy and 14 controls, blood pressure, heart rate, and plasma concentrations of norepinephrine, epinephrine, GLP-1, glucagon, insulin, and glucose were measured after oral glucose. In gastrectomy patients, GLP-1, norepinephrine, and heart rate peaked 15 to 30 min after oral glucose. Significant positive correlations were found among GLP-1, norepinephrine, and heart rate at 30 min, and these parameters at 30 min were significantly higher in patients with early dumping syndrome. These results suggest that GLP-1 is involved in the pathophysiology of early dumping syndrome.
引用
收藏
页码:2263 / 2267
页数:4
相关论文
共 50 条
  • [1] A possible role of GLP-1 in the pathophysiology of early dumping syndrome
    Yamamoto, H
    Mori, T
    Tsuchihashi, H
    Akabori, H
    Naito, H
    Tani, T
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (12) : 2263 - 2267
  • [2] Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome
    Gebhard, B
    Holst, JJ
    Biegelmayer, C
    Miholic, J
    DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (09) : 1915 - 1923
  • [3] Postprandial GLP-1, Norepinephrine, and Reactive Hypoglycemia in Dumping Syndrome
    B. Gebhard
    J.J. Holst
    C. Biegelmayer
    J. Miholic
    Digestive Diseases and Sciences, 2001, 46 : 1915 - 1923
  • [4] Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential
    Torekov, S. S.
    Madsbad, S.
    Holst, J. J.
    OBESITY REVIEWS, 2011, 12 (08) : 593 - 601
  • [5] Physiology and pathophysiology of glucagon-like peptide-1 (GLP-1): The role of GLP-1 in the pathogenesis of diabetes mellitus, obesity, and stress
    Bojanowska, E
    MEDICAL SCIENCE MONITOR, 2005, 11 (08): : RA271 - RA278
  • [6] Possible Role of GLP-1 and Its Agonists in the Treatment of Type 1 Diabetes Mellitus
    Claire M. Issa
    Sami T. Azar
    Current Diabetes Reports, 2012, 12 : 560 - 567
  • [7] Possible Role of GLP-1 and Its Agonists in the Treatment of Type 1 Diabetes Mellitus
    Issa, Claire M.
    Azar, Sami T.
    CURRENT DIABETES REPORTS, 2012, 12 (05) : 560 - 567
  • [8] Possible role of GLP-1 in antidepressant effects of metformin and exercise in CUMS mice
    Liu Weina
    Liu Jiatong
    Huang Zhuochun
    Cui Zhiming
    Li Lingxia
    Liu Wenbin
    Qi Zhengtang
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 246 : 486 - 497
  • [9] The role for GLP-1 in feeding regulation
    Date, Yukari
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2013, 63 : S92 - S92
  • [10] Metabolic Syndrome and the Role of GLP-1 Receptor Agonists in a Model of Postmenopausal PCOS
    Fernandez, Edgar D. Torres
    Romero, Damian G.
    Cardozo, Licy L. Yanes
    FASEB JOURNAL, 2018, 32 (01):